In the SURMOUNT-1 trial of tirzepatide, participants on the 15 milligram dose lost an average of 20.9 percent of their body weight over 72 weeks, while the STEP 1 trial of once-weekly semaglutide reported about 14.9 percent over 68 weeks
Khafagy, R
These lipid-based NPs can selectively internalize into airway epithelial cells, which could lead to successful transfection and the restoration of gene expression
Our Webster clinic offers: Physician-supervised weight loss programs Personalized treatment plans GLP-1 medications, including Semaglutide and Tirzepatide Nutrition and lifestyle counseling Body composition analysis Long-term maintenance programs Ongoing accountability and follow-up care We understand that weight loss is not one-size-fits-all
It also impacts cellular signalling in brain tissue, with potential applications in targeting neurodegenerative diseases and alleviating brain fog
(Source: Healthline, May 2026) Sequential Treatment Is Increasingly Common And Works Well A separate 2026 analysis found that patients who started on GLP-1 therapy and later transitioned to bariatric surgery whether due to side effects, medication unavailability, or seeking definitive treatment had surgical outcomes and quality-of-life scores comparable to patients who went straight to surgery